By: Patrick Temple-West
Technology behind blockbuster Covid-19 jabs is now yielding promising results in oncology treatment
Patrick Temple-West is a Governance Reporter at the Financial Times. He covers corporate governance and securities regulations, with a keen focus on the intersection of finance and healthcare, including topics such as consumer health, medical technology, and digital health innovations. His work has been featured in prominent publications including The Australian Financial Review, New Zealand Herald, and Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Patrick's coverage spans environment, finance & economy, and business topics with a focus on investment analysis, expert commentary, and legal policy regulation. Pitches should offer in-depth insights into environmental or financial trends to attract his attention. He appears receptive to sources providing expert commentary on government announcements related to the environment.
Given Patrick's interest in ESG (Environmental, Social, and Governance), renewable energy, climate change as well as Wall Street-related topics such as investing and corporate governance; pitches should provide expertise in these areas. Additionally, given his focus on investment analysis and finance & economy themes, he may be interested in receiving data-driven analyses of market trends within these sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .